Sudden cardiac death after treatment with low dose risperidone in combination with cotrimoxazole

Asian Journal of Psychiatry

Volumn 4, Issue 3, 2011, Pages 218-220

  Rajabi, Fariba ^a   Hajsheikholeslami, Farhad ^b   Beyraghi, Narges ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cotrimoxazole; QT dispersion; Risperidone; Sudden cardiac death

Indexed keywords

COTRIMOXAZOLE; RISPERIDONE;

ACUTE PSYCHOSIS; ADULT; CASE REPORT; DRUG FATALITY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; LOW DRUG DOSE; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; SUDDEN DEATH; URINARY TRACT INFECTION;

EID: 80052961454     PISSN: 18762018     EISSN: 18762026     Source Type: Journal    
DOI: 10.1016/j.ajp.2011.05.006     Document Type: Note

References (19)

1. Bril F., Gonzalez C.D., Di Girolamo G. Antimicrobial agents-associated with QT interval prolongation. Current Drug Safety 2010, 5(1):85-92.
2. de Bruyne M.C., Hoes A.W., Kors J.A., Hofman A., van Bemmel J.H., Grobbee D.E. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation 1998, 97(5):467-472.
3. Drolet B., Yang T., Daleau P., Roden D.M., Turgeon J. Risperidone prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current. Journal of Cardiovascular Pharmacology 2003, 41(6):934-937.
4. Gluais P., Bastide M., Grandmougin D., Fayad G., Adamantidis M. Risperidone reduces K+ currents in human atrial myocytes and prolongs repolarization in human myocardium. European Journal of Pharmacology 2004, 497(2):215-222.
5. Lehmann M.H., Suzuki F., Fromm B.S., Frankovich D., Elko P., Steinman R.T., Fresard J., Baga J.J., Taggart R.T. T wave " humps" as a potential electrocardiographic marker of the long QT syndrome. Journal of the American College of Cardiology 1994, 24(3):746-754.
6. Lopez J.A., Harold J.G., Rosenthal M.C., Oseran D.S., Schapira J.N., Peter T. QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole. The American Journal of Cardiology 1987, 59(4):376-377.
7. Parish D.C., Dinesh Chandra K.M., Dane F.C. Success changes the problem: why ventricular fibrillation is declining, why pulseless electrical activity is emerging, and what to do about it. Resuscitation 2003, 58(1):31-35.
8. Rasmussen K.G., Hooten W.M., Dodd M.L., Ryan D.A. QTc dispersion on the baseline ECG predicts arrhythmias during electroconvulsive therapy. Acta Cardiologica 2007, 62(4):345-347.
9. Ray W.A., Chung C.P., Murray K.T., Hall K., Stein C.M. Atypical antipsychotic drugs and the risk of sudden cardiac death. The New England Journal of Medicine 2009, 360(3):225-235.
10. Ray W.A., Meredith S., Thapa P.B., Meador K.G., Hall K., Murray K.T. Antipsychotics and the risk of sudden cardiac death. Archives of General Psychiatry 2001, 58(12):1161-1167.
11. Reddy P.R., Reinier K., Singh T., Mariani R., Gunson K., Jonathan J., Chugh S.S. Physical activity as a trigger of sudden cardiac arrest: the Oregon Sudden Unexpected Death Study. International Journal of Cardiology 2009, 131(3):345-349.
12. Stollberger C., Huber J.O., Finsterer J. Antipsychotic drugs and QT prolongation. International Clinical Psychopharmacology 2005, 20(5):243-251.
13. Straus S.M., Bleumink G.S., Dieleman J.P., van der Lei J., 't Jong G.W., Kingma J.H., Sturkenboom M.C., Stricker B.H. Antipsychotics and the risk of sudden cardiac death. Archives of Internal Medicine 2004, 164(12):1293-1297.
14. Thomas S.H. Drugs QT interval abnormalities and ventricular arrhythmias. Adverse Drug Reactions and Toxicological Reviews 1994, 13(2):77-102.
15. Wedekind H., Schulze-Bahr E., Djonlagic H. Postextrasystolic " T wave hump" augmentation as a marker of increased arrhythmogenic risk in the long QT syndrome. Heart 2002, 88(6):633.
16. Welch R., Chue P. Antipsychotic agents QT changes. Journal of Psychiatry & Neuroscience 2000, 25(2):154-160.
17. Yerrabolu M., Prabhudesai S., Tawam M., Winter L., Kamalesh M. Effect of risperidone on QT interval and QT dispersion in the elderly. Heart Disease 2000, 2(1):10-12.
18. Zareba W., Lin D.A. Antipsychotic drugs and QT interval prolongation. The Psychiatric Quarterly 2003, 74(3):291-306.
19. Zipes D.P., Wellens H.J. Sudden cardiac death. Circulation 1998, 98(21):2334-2351.